Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Cash & Equivalents	94.61	244.66	8.46	1.32
Short-Term Investments	103.37	0	0	0
Cash & Cash Equivalents	197.98	244.66	8.46	1.32
Cash Growth	-19.08%	2793.01%	542.14%	-
Other Current Assets	4.14	3.31	0.11	0.06
Total Current Assets	202.12	247.97	8.57	1.38
Property, Plant & Equipment	4.75	0.01	0	0
Long-Term Investments	13.82	0	0	0
Other Long-Term Assets	1.76	2.95	0.04	0.04
Total Long-Term Assets	20.33	2.96	0.04	0.05
Total Assets	222.45	250.93	8.61	1.43
Accounts Payable	4.97	1	1.13	0.29
Current Debt	0.74	0	0	0
Other Current Liabilities	5.41	2.68	0.46	0.33
Total Current Liabilities	11.13	3.68	1.6	0.62
Long-Term Debt	3.24	0	0	0
Other Long-Term Liabilities	0.47	0.82	0	3.36
Total Long-Term Liabilities	3.7	0.82	0	3.36
Total Liabilities	14.83	4.5	1.6	3.98
Total Debt	3.98	0	0	0
Common Stock	320.19	308.01	0	0.81
Retained Earnings	-112.19	-61.58	-34.27	-10.22
Comprehensive Income	-0.39	0	0	0
Shareholders' Equity	207.62	246.43	-34.27	-9.41
Net Cash / Debt	194	244.66	8.46	1.32
Net Cash / Debt Growth	-20.71%	2793.01%	542.14%	-
Net Cash Per Share	5.04	25.40	14.88	8.28
Working Capital	190.99	244.29	6.98	0.77
Book Value Per Share	5.39	25.59	-60.28	-59.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).